Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Endoscopic topical therapy for the treatment of Helicobacter pylori infection.

Kihira K, Satoh K, Saifuku K, Taniguchi Y, Takimoto T, Yoshida Y, Ishino Y, Yamamoto H, Kimura K.

J Gastroenterol. 1996 Nov;31 Suppl 9:66-8.

PMID:
8959524
2.

A 1-h topical therapy for the treatment of Helicobacter pylori infection.

Kimura K, Ido K, Saifuku K, Taniguchi Y, Kihira K, Satoh K, Takimoto T, Yoshida Y.

Am J Gastroenterol. 1995 Jan;90(1):60-3.

PMID:
7801950
3.

Comparison of two 3-day Helicobacter pylori eradication regimens with a standard 1-week regimen.

Grimley CE, Penny A, O'sullivan M, Shebani M, Lismore JR, Cross R, Illing RC, Loft DE, Nwokolo CU.

Aliment Pharmacol Ther. 1999 Jul;13(7):869-73.

4.

Treatment of Helicobacter pylori infection by topical administration of antimicrobial agents.

Satoh K.

Scand J Gastroenterol Suppl. 1996;214:56; discussion 57-60.

PMID:
8722409
5.
6.

[Comparative effect of lansoprazole/amoxicillin with omeprazole/amoxicillin for the eradication of Helicobacter pylori in patients with duodenal ulcer].

Kayser S, Flury R, Zbinden R, Fried M, Wirth HP.

Schweiz Med Wochenschr. 1997 Apr 26;127(17):722-7. German.

PMID:
9221483
7.

Low-dose lansoprazole and clarithromycin plus metronidazole vs. full-dose lansoprazole and clarithromycin plus amoxicillin for eradication of Helicobacter pylori infection.

Bazzoli F, Zagari RM, Pozzato P, Fossi S, Ricciardiello L, Nicolini G, De Luca L, Berretti D, Alampi G, Di Pietro C, Morelli P, Roda E.

Aliment Pharmacol Ther. 2002 Jan;16(1):153-8.

8.

Randomized comparison of 1-hour topical method vs. amoxycillin plus omeprazole for eradication of Helicobacter pylori in duodenal ulcer patients.

Przytulski K, Regula J, Dziurkowska-Marek A, Kohut M, Hennig E, Marek T, Ostrowski J, Nowak A, Butruk E.

Aliment Pharmacol Ther. 1998 Jan;12(1):69-75.

9.

Randomized clinical trial comparing two one-week triple-therapy regimens for the eradication of Helicobacter pylori infection and duodenal ulcer healing.

Forné M, Viver JM, Esteve M, Fernández-Bañares F, Lite J, Espinós JC, Quintana S, Salas A, Garau J.

Am J Gastroenterol. 1998 Jan;93(1):35-8.

PMID:
9448170
10.

Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance?

Lerang F, Moum B, Haug JB, Tolås P, Breder O, Aubert E, Høie O, Søberg T, Flaaten B, Farup P, Berge T.

Am J Gastroenterol. 1997 Feb;92(2):248-53.

PMID:
9040200
11.

Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection.

Harford W, Lanza F, Arora A, Graham D, Haber M, Weissfeld A, Rose P, Siepman N.

Helicobacter. 1996 Dec;1(4):243-50.

PMID:
9398875
12.

Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial.

Chey WD, Fisher L, Elta GH, Barnett JL, Nostrant T, DelValle J, Hasler WL, Scheiman JM.

Am J Gastroenterol. 1997 Sep;92(9):1483-6.

PMID:
9317068
13.

The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.

Bago J, Halle ZB, Strinić D, Kućisec N, Jandrić D, Bevanda M, Tomić M, Bilić A.

Wien Klin Wochenschr. 2002 Jun 28;114(12):448-53.

PMID:
12422579
14.

The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori.

Uygun A, Kadayifci A, Safali M, Ilgan S, Bagci S.

J Dig Dis. 2007 Nov;8(4):211-5.

PMID:
17970879
15.

One-day quadruple therapy compared with 7-day triple therapy for Helicobacter pylori infection.

Lara LF, Cisneros G, Gurney M, Van Ness M, Jarjoura D, Moauro B, Polen A, Rutecki G, Whittier F.

Arch Intern Med. 2003 Sep 22;163(17):2079-84.

PMID:
14504122
16.

Four-day lansoprazole-quadruple therapy in the routine treatment of Helicobacter pylori infection.

de Boer WA, van Etten RJ, Schneeberger PM.

Neth J Med. 1998 Jan;52(1):10-5.

PMID:
9573736
17.

Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?

Güliter S, Keleş H, Ozkurt ZN, Cengiz DU, Kolukisa E.

Turk J Gastroenterol. 2005 Mar;16(1):29-33.

18.

Incidence of duodenal ulcer healing after 1 week of proton pump inhibitor triple therapy for eradication of Helicobacter pylori. The Lansoprazole Helicobacter Study Group.

Harris AW, Misiewicz JJ, Bardhan KD, Levi S, O'Morain C, Cooper BT, Kerr GD, Dixon MF, Langworthy H, Piper D.

Aliment Pharmacol Ther. 1998 Aug;12(8):741-5.

19.

Omeprazole triple therapy versus omeprazole quadruple therapy for healing duodenal ulcer and eradication of Helicobacter pylori infection: a 24-month follow-up study.

Mantzaris GJ, Petraki K, Archavlis E, Amberiadis P, Christoforidis P, Kourtessas D, Chiotakakou E, Triantafyllou G.

Eur J Gastroenterol Hepatol. 2002 Nov;14(11):1237-43.

PMID:
12439119
20.

A comparison between omeprazole-based triple therapy and bismuth-based triple therapy for the treatment of Helicobacter pylori infection: a prospective randomized 1-yr follow-up study.

Lerang F, Moum B, Ragnhildstveit E, Haug JB, Hauge T, Tolås P, Aubert E, Henriksen M, Efskind PS, Nicolaysen K, Søberg T, Odegaard A, Berge T.

Am J Gastroenterol. 1997 Apr;92(4):653-8.

PMID:
9128317

Supplemental Content

Support Center